Education
About Us
Working with TipRanks
Follow Us
TOUS - ETF AI Analysis
Top Page
T. Rowe Price International Equity ETF (TOUS)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, such as Rolls-Royce and UniCredit, have delivered strong year-to-date performance, driving the fund’s returns.
Global Diversification
The ETF invests across multiple countries, including Japan, the UK, and France, reducing reliance on any single market.
Balanced Sector Exposure
The fund is spread across various sectors like Financials, Industrials, and Technology, helping to mitigate sector-specific risks.
Negative Factors
Moderate Expense Ratio
The ETF’s expense ratio is higher than some low-cost alternatives, which could slightly reduce long-term returns.
Underperforming Holdings
Some top holdings, like SAP SE, have shown weak year-to-date performance, potentially dragging on overall returns.
Limited U.S. Exposure
With only 10% of assets in U.S. companies, the fund may miss out on opportunities in the world’s largest economy.
TOUS vs. SPDR S&P 500 ETF (SPY)
AUM1.12B
RegionDeveloped Markets
Expense Ratio0.50%
Beta0.69
IssuerT. Rowe Price
Inception DateJun 14, 2023
Dividend Yield1.7%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume144,828
30 Day Avg. Volume174,557
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
38.64Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering175
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TOUS Summary
The T. Rowe Price International Equity ETF (TOUS) is an investment fund that gives you access to a wide range of companies from around the world, including both developed and emerging markets. It focuses on a 'Total Market' approach, meaning it includes companies of all sizes and styles. Some well-known companies in this ETF are ASML Holding NV and AstraZeneca. This ETF is a good option for investors looking to diversify their portfolio globally and benefit from international growth opportunities. However, since it invests in global markets, its performance can be affected by economic and political changes in different countries.
How much will it cost me?The T. Rowe Price International Equity ETF (TOUS) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers are selecting investments rather than tracking a passive index.
What would affect this ETF?The T. Rowe Price International Equity ETF (TOUS) could benefit from growth in developed markets outside the U.S., particularly in sectors like financials, technology, and health care, which make up a significant portion of its holdings. However, potential risks include economic slowdowns in key regions, regulatory changes affecting top holdings like ASML or AstraZeneca, and currency fluctuations that could impact returns for U.S.-based investors. Global interest rate changes and geopolitical tensions may also influence the ETF's performance.
TOUS Top 10 Holdings
The T. Rowe Price International Equity ETF (TOUS) leans heavily into developed markets outside the U.S., with a notable focus on financials and industrials. Barclays and Rolls-Royce are rising stars, driving performance with strong earnings and strategic initiatives, while Unilever is lagging, weighed down by bearish momentum and valuation concerns. ASML Holding adds steady growth from the tech sector, while Roche Holding shines in healthcare with its robust pharmaceutical pipeline. Overall, the fund’s diverse mix of sectors and regions provides a balanced approach, though its reliance on financials may amplify risks in volatile market conditions.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.06% | $34.31M | €401.77B | 41.34% | 76 Outperform | |
| AstraZeneca | 2.62% | $29.44M | $296.12B | 41.20% | 79 Outperform | |
| Rolls-Royce Holdings | 2.17% | $24.40M | £105.77B | 137.12% | 71 Outperform | |
| UniCredit SpA | 1.86% | $20.88M | €109.58B | 97.88% | 75 Outperform | |
| Roche Holding AG | 1.50% | $16.77M | CHF270.15B | 45.02% | 73 Outperform | |
| Siemens | 1.40% | $15.72M | €199.94B | 30.63% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 1.32% | $14.84M | ¥29.29T | 44.25% | 76 Outperform | |
| Renesas Electronics | 1.32% | $14.77M | ¥4.18T | 16.65% | 64 Neutral | |
| Barclays | 1.27% | $14.25M | £66.36B | 82.32% | 78 Outperform | |
| Unilever | 1.25% | $14.04M | £100.99B | -9.50% | 72 Outperform |
TOUS Technical Analysis
Positive
―
Price Trends
33.77
Positive
33.37
Positive
31.92
Positive
Market Momentum
0.46
Negative
70.39
Negative
85.84
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TOUS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.52, equal to the 50-day MA of 33.77, and equal to the 200-day MA of 31.92, indicating a bullish trend. The MACD of 0.46 indicates Negative momentum. The RSI at 70.39 is Negative, neither overbought nor oversold. The STOCH value of 85.84 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TOUS.
TOUS Peer Comparison
Comparison Results
Performance Comparison
TOUS
T. Rowe Price International Equity ETF
35.36
9.72
37.91%
DIHP
Dimensional International High Profitability ETF
―
―
―
DFIS
Dimensional International Small Cap ETF
―
―
―
DISV
Dimensional International Small Cap Value ETF
―
―
―
CGIE
Capital Group International Equity ETF
―
―
―
AVIV
Avantis International Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents